INDRANILL BASU-RAY

BACKGROUND: The ongoing novel coronavirus disease 2019 (COVID-19) pandemic has a significant mortality rate of 3-5%. The principal causes of multiorgan failure and death are cytokine release syndrome and immune dysfunction. Stress, anxiety, and depression has been aggravated by the pandemic and its resultant restrictions in day-to-day life which may contribute to immune dysregulation.

BACKGROUND: Catheter ablation is an effective treatment for ventricular arrhythmia (VA) in ischemic cardiomyopathy (ICM). However, results in non-ICM (NICM) patients are not satisfactory, and studies comparing differences between NICM and ICM are limited. We conducted a meta-analysis of procedural characteristics and long-term outcomes of catheter ablation for VA, comparing results between ICM and NICM. METHODS: Studies in the PubMed, EMBASE, and Cochrane databases were systematically reviewed.

By  Indranill Basu-Ray In the heart of America, a silent battle rages on. Each year, a staggering 670,000 lives are claimed by coronary heart disease, a stealthy foe often linked to the heart’s cry for more oxygen. In this landscape, where 20% of heart failure warriors grapple with their heart’s weakened ability to soak in life-giving oxygen, a hero emerges from the shadows. It’s not a new pharmaceutical wonder drug or a high-tech medical procedure.